Language: English
Published by London: MD Martin Dunitz, 2002
ISBN 10: 1841841579 ISBN 13: 9781841841571
Seller: Zubal-Books, Since 1961, Cleveland, OH, U.S.A.
Condition: Good. *Price HAS BEEN REDUCED by 10% until Monday, Jan. 5 (weekend sale item)* 256 pp., hardcover, ex library, else text clean & binding tight, good. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.
Seller: J. HOOD, BOOKSELLERS, ABAA/ILAB, Baldwin City, KS, U.S.A.
Hardcover. 396pp. Near new condition, covers bright, text clean & binding tight.
Hardcover. Condition: Near Fine. 1841841579. Pictorial board hardcover, from closed pharmaceutical company library. Lending record shows this book has never been borrowed. 751 pages, index, illustrated with charts, tables and diagrams. The development of biological therapies, and their use in animal and human studies of rheumatological disease. Part A covers targets of emerging therapies - targeting/manipulating cells, targeting cell surface receptors, targeting cytokines, inflammatory mediators and transcription factors, and targeting plasma molecules. Part B then examines the use and implementation of these new therapies in the clinic, covering their use in treating specific rheumatological conditions. Part C discusses issues relating to study design and regulatory issues in the US and Europe. Contents clean, tight and bright. Book.
Seller: Great Matter Books, Grand Rapids, MI, U.S.A.
First Edition
Hardcover. Condition: As New. 1st Edition. As New, no flaws inside or out. All of our books are individually inspected and described. Never ex-library unless explicitly described as such.
Language: English
Published by Informa Healthcare, London, 2007
ISBN 10: 1841844845 ISBN 13: 9781841844848
Seller: Tiber Books, Cockeysville, MD, U.S.A.
Hardcover. Condition: Very Good. . . . . Small 4to, hardcover, no dj, as issued. Vg condition. Shallow crinkle to opening & closing few pgs; Contents bright & clean, no markings or highlighting; covers glossy. 633 pp., illus.
Seller: The Book Exchange, Macclesfield, CHESH, United Kingdom
US$ 26.62
Quantity: 1 available
Add to basketHardcover. Condition: Near Fine. 3540297138. Unread Pictorial board hardcover, from closed pharmaceutical company library. Lending record shows this book has never been borrowed. 291 pages, index, illustrated with charts, tables and diagrams. Paper clip mark on front endpaper, otherwise contents clean, tight and bright. Text in English. Book.
Condition: Sehr gut. 768 Seiten kaum benutzt aus einer Firmenbibliothek Sprache: Englisch Gewicht in Gramm: 1778 25,5 x 19,5 x 3,7 cm, Gebundene Ausgabe.
Seller: HPB-Red, Dallas, TX, U.S.A.
hardcover. Condition: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: New.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 68.38
Quantity: Over 20 available
Add to basketCondition: New. In.
Language: English
Published by Elsevier Science Health Science, 2018
ISBN 10: 0323548237 ISBN 13: 9780323548236
Seller: Revaluation Books, Exeter, United Kingdom
US$ 97.34
Quantity: 2 available
Add to basketPaperback. Condition: Brand New. 1st edition. 207 pages. 9.00x7.25x0.50 inches. In Stock.
Condition: New. pp. 400.
Seller: Revaluation Books, Exeter, United Kingdom
US$ 93.66
Quantity: 2 available
Add to basketPaperback. Condition: Brand New. reprint edition. 420 pages. 9.25x6.10x0.90 inches. In Stock.
Condition: New. pp. 400.
Condition: New. pp. 400.
Seller: Mispah books, Redhill, SURRE, United Kingdom
US$ 104.02
Quantity: 1 available
Add to basketHardcover. Condition: Like New. Like New. Ships from Multiple Locations. book.
Language: English
Published by Springer, Chapman And Hall/CRC, 2011
ISBN 10: 1461392683 ISBN 13: 9781461392682
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Leukocyte adhesion molecules have been the subject of intense basic and preclinical research. Results from clinical trials obtained sofar with antibodies directed towards these surface proteins offer promise for the prevention of graft rejection and effective treatment of acute and chronic inflammatory disease. This volume presents a comprehensive review of contemporary research on the structure, function and regulation of leukocyte adhesion molecules and their ligands, from the molecular to the clinical level. The blend of basic science and clinical applications presented in Structure, Function and Regulation of Molecules Involved in Leukocyte Adhesion provides clear evidence of the biological importance of cell-cell interactions and the many potential clinical dividends afforded by understanding the molecular basis of cell adhesion. It will appeal to a broad range of readers in immunology and cell biology.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Seller: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Brand new book. Fast ship. Please provide full street address as we are not able to ship to P O box address.
US$ 153.95
Quantity: 1 available
Add to basketPaperback. Condition: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 255.61
Quantity: Over 20 available
Add to basketCondition: New. In.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 255.61
Quantity: Over 20 available
Add to basketCondition: New. In.
US$ 244.10
Quantity: 1 available
Add to basketHardcover. Condition: Like New. Like New. book.
Condition: New. pp. vii + 280.
Language: English
Published by Springer Berlin Heidelberg, Springer Berlin Heidelberg Apr 2006, 2006
ISBN 10: 3540297138 ISBN 13: 9783540297130
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Buch. Condition: Neu. Neuware -The immune system has been known to be capable of distinguishing self from non-self since the pioneering work of Paul Erhlich more than a century ago. Originally described in experiments studying blood transfusion comp- ibility, the principle of ¿horror autotoxicus¿ is still valid, although today the phenomenon is usually described in terms of tolerance or ignorance. A great deal has been learned about the various processes preventing self-reactivity normally. These include processes that operate during immune cell ontogeny and subsequently on reactivity of mature lymphocytes in the periphery. They encompass mechanisms that are intrinsic to potentially reactive lymphocytes and can result in central or peripheral deletion or the alteration of functional potential. In addition, there are in uences that are extrinsic to potentially auto-reactive lymphocytes, including the function of regulatory cells, d- ferentiation state of antigen-presenting cells, availability of self-antigen, the cytokine and chemokine milieu, as well as the traf cking patterns involved in generating productive immune interactions. It is clear that the immune system devotes a considerable effort to the avoidance of the development of potentially pathogenic self-reactivity. Despite this, the development of self-reactivity is relatively common. - though the development of autoimmune disease is less frequent, autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, systemic lupus e- thematosus, psoriasis, thyroiditis, and myasthenia gravis, are all too common, and can cause considerable morbidity and even mortality. 296 pp. Englisch.
Language: English
Published by Springer Berlin Heidelberg, Springer Berlin Heidelberg, 2010
ISBN 10: 364206745X ISBN 13: 9783642067457
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The immune system has been known to be capable of distinguishing self from non-self since the pioneering work of Paul Erhlich more than a century ago. Originally described in experiments studying blood transfusion comp- ibility, the principle of 'horror autotoxicus' is still valid, although today the phenomenon is usually described in terms of tolerance or ignorance. A great deal has been learned about the various processes preventing self-reactivity normally. These include processes that operate during immune cell ontogeny and subsequently on reactivity of mature lymphocytes in the periphery. They encompass mechanisms that are intrinsic to potentially reactive lymphocytes and can result in central or peripheral deletion or the alteration of functional potential. In addition, there are in uences that are extrinsic to potentially auto-reactive lymphocytes, including the function of regulatory cells, d- ferentiation state of antigen-presenting cells, availability of self-antigen, the cytokine and chemokine milieu, as well as the traf cking patterns involved in generating productive immune interactions. It is clear that the immune system devotes a considerable effort to the avoidance of the development of potentially pathogenic self-reactivity. Despite this, the development of self-reactivity is relatively common. - though the development of autoimmune disease is less frequent, autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, systemic lupus e- thematosus, psoriasis, thyroiditis, and myasthenia gravis, are all too common, and can cause considerable morbidity and even mortality.